Contact us   |  

Present and future of TTP treatment

Present and future of TTP treatment

28/04/2021 16:00

Speakers: Paul Coppo

Target: Health professionals
Subnetworks: Bleeding - Coagulation disorders
Disease Groups: Rare thrombotic disorder due to quantitative platelet anomaly (Low)

Paul Coppo is professor of Haematology at Sorbonne University in Paris. He heads the French reference center for thrombotic microangiopathies (CNR-MAT) and the department of lymphoid malignancies in Saint-Antoine hospital (Paris, France), involved in the management of rare lymphoid malignancies and other immuno-hematological diseases. He is member of the team Immunopathology and Immuno-intervention (Equipe 16, INSERM UMRS 1138, Centre de Recherche des Cordeliers, Sorbonne University).

Dr Coppo received his medical degree from Sorbonne University in 2003 and completed his residency at Saint-Antoine Hospital. He completed his PhD in the Laboratory of Dr Vainchenker (Institut Gustave Roussy, Villejuif) in 2006. Paul Coppo set up ex-nihilo the CNR-MAT, which is a resourse center for the diagnosis and the management of thrombotic microangiopathies.

The works of his team include clinical trials and translational research works which have been published in Blood, Leukemia, Lancet Haematology, Haematologica and the Journal of Thrombosis and Haemostasis.